Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abcellera Biologics Inc (ABCL)

Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abcellera Biologics Inc 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 CAN

www.abcellera.com Employees: 562 P: 604-559-9005

Sector:

Medical

Description:

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635 and ABCL575. AbCellera Biologics Inc. is based in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 1,215,672
Enterprise Value, $K 1,062,162
Shares Outstanding, K 303,160
Float, K 215,547
% Float 71.10%
Short Interest, K 50,425
Short Float 16.63%
Days to Cover 22.71
Short Volume Ratio 0.60
% of Insider Shareholders 28.90%
% of Institutional Shareholders 61.42%

Financials:

Annual Sales, $ 75,130 K
Annual Net Income, $ -146,410 K
Last Quarter Sales, $ 44,850 K
Last Quarter Net Income, $ -8,950 K
EBIT, $ -194,940 K
EBITDA, $ -166,120 K

Growth:

1-Year Return 61.57%
3-Year Return -44.38%
5-Year Return -86.33%
5-Year Revenue Growth -67.78%
5-Year Earnings Growth -208.89%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 02/24/26
Next Earnings Date 05/11/26 [AMC]
Earnings Per Share ttm -0.49
EPS Growth vs. Prev Qtr 84.21%
EPS Growth vs. Prev Year 72.73%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ABCL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -15.05%
Return-on-Assets % -10.92%
Profit Margin % -194.88%
Debt/Equity 0.00
Price/Sales 15.45
Price/Cash Flow N/A
Price/Book 1.19
Book Value/Share 3.23
Interest Coverage -1.13
60-Month Beta 0.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.